Table 1.
Treatment | Target Disease | Concept | References |
---|---|---|---|
Low-carbohydrate diet | NICCD CTLN2 |
Basal therapy | [18,47,48] |
MCT + lactose-restricted formula | NICCD CTLN2 |
Energy supply Correction of metabolic disorder |
[53,54,55,56,57,58] |
Sodium pyruvate | CTLN2 | Energy supply Correction of metabolic disorder |
[59,60,61,62] |
Ursodeoxycholic acid | NICCD | Hepatoprotection Anti-cholestasis |
[18,63,64,65] |
Mannitol | NICCD CTLN2 |
Osmotic agent for treating brain edema due to hyperammonemia | [51] |
Liver transplantation * | NICCD CTLN2 |
Ultimate fundamental therapy | [16,66,67,68,69] |
* In Japan, liver transplantation is performed on recipients under 65 years old. CTLN-2, adult-onset type II citrullinemia; NICCD, neonatal intrahepatic cholestasis caused by citrin deficiency; MCT, medium-chain triglycerides.